GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
99 hedge funds and large institutions have $657M invested in GenMark Diagnostics, Inc in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
+13
Holders Change %
+15.12%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
50
Reduced
13
Closed
6
Calls
$58K
Puts
–
Net Calls
+$58K
Net Calls Change
-$8K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.3M |
| 3 |
CCM
Cadian Capital Management
New York
|
+$9.45M |
| 4 |
JPMorgan Chase & Co
New York
|
+$6.62M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$6.18M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.69M |
| 2 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$5.93M |
| 3 |
Morgan Stanley
New York
|
-$3.72M |
| 4 |
Two Sigma Investments
New York
|
-$1.01M |
| 5 |
Two Sigma Advisers
New York
|
-$536K |
